Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Trigem Anti-idiotype (Anti-Id) Monoclonal Antibody (MAb) Treatment for Stage III Melanoma: Results of a Multicenter Phase II Trial

Safa M, Lutzky J, Chatterjee M, Sussman J, Bard V, Baral D, Das R, Saha A, Shukla R, Reisfeld R, Hutchins LF, Bhatnagar A, Foon K. Trigem Anti-idiotype (Anti-Id) Monoclonal Antibody (MAb) Treatment for Stage III Melanoma: Results of a Multicenter Phase II Trial. 2001.


collapse authors with profiles